Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels Cristiana RossiLuigi Alberto PiniPaola Sarchielli Clinical Trial 15 November 2007 Pages: 1 - 8
CYP2C9 genotypes and the quality of anticoagulation control with warfarin therapy among Brazilian patients M. V. LimaG. S. RibeiroR. Vianna-Jorge Pharmacogenetics 23 October 2007 Pages: 9 - 15
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine Janne T. BackmanMarika T. SchröderPertti J. Neuvonen Pharmacokinetics and Disposition 23 October 2007 Pages: 17 - 24
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl Teijo I. SaariKari LaineKlaus T. Olkkola Pharmacokinetics and Disposition 07 November 2007 Pages: 25 - 30
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition Ashok RakhitMichael P. PantzeMarta Hamilton Pharmacokinetics and Disposition 14 November 2007 Pages: 31 - 41
Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil Gary BurgessHans HoogkamerJasper Dingemanse Pharmacokinetics and Disposition 27 November 2007 Pages: 43 - 50
Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study Agnès SoudryCarole DufouilAnnick Alpérovitch Pharmacoepidemiology and Prescription 19 October 2007 Pages: 51 - 59
Development of NSAIDs prescription indicators based on health outcomes Rocío Fernández UrrusunoMiguel Pedregal GonzálezMa Amparo Torrecilla Rojas Pharmacoepidemiology and Prescription 31 October 2007 Pages: 61 - 67
The conscientious judgement of a DSMB – statistical stopping rules re-examined Karin HedenmalmHans MelanderGunnar Alvan Debate Article 14 November 2007 Pages: 69 - 72
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients Macarena C. CáceresEva María Peñas-LLedóAdrián LLerena Short Communication 19 October 2007 Pages: 73 - 76
Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine Yetunde T. KoladeChinedum P. BabalolaGerhard K. E. Scriba Short Communication 20 October 2007 Pages: 77 - 81
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels Stéphanie BadiouHélène BretonDominique Hillaire-Buys Short Communication 31 October 2007 Pages: 83 - 87
Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole Ai MiharaTakehiko MoriShinichiro Okamoto Short Communication 28 October 2007 Pages: 89 - 91
Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam Mária TóthSándor DrabantImre Klebovich Letter to the Editors 08 November 2007 Pages: 93 - 94